What is he best known for?
The fields of study he is best known for:
- Cancer
- Nanoparticle
- Organic chemistry
His scientific interests lie mostly in Nanotechnology, Nanoparticle, Drug delivery, Photodynamic therapy and Photothermal therapy.
Yunlu Dai has researched Nanotechnology in several fields, including Biocompatibility, Luminescence, Photon upconversion and Mesoporous silica, Mesoporous material.
His research in Luminescence intersects with topics in Conjugated system and Photochemistry.
He combines subjects such as Prodrug, Nanowire and Surface modification with his study of Nanoparticle.
His Drug delivery research is multidisciplinary, incorporating perspectives in Nanocomposite, Micelle and Controlled release.
His Photodynamic therapy research incorporates themes from Optoelectronics, Photosensitizer and Doxorubicin.
His most cited work include:
- Synthesis of Magnetic, Up‐Conversion Luminescent, and Mesoporous Core–Shell‐Structured Nanocomposites as Drug Carriers (477 citations)
- In Vivo Multimodality Imaging and Cancer Therapy by Near-Infrared Light-Triggered trans-Platinum Pro-Drug-Conjugated Upconverison Nanoparticles (400 citations)
- Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment (301 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Nanotechnology, Nanoparticle, Drug delivery, Luminescence and Photodynamic therapy.
His Nanotechnology research incorporates elements of Biocompatibility, Mesoporous silica, Mesoporous material and Photon upconversion.
His research integrates issues of Ethylene glycol, Polymer, Prodrug, Photochemistry and Dispersity in his study of Nanoparticle.
His studies deal with areas such as Conjugated system, Nanocomposite, Controlled release and Nuclear chemistry as well as Drug delivery.
The concepts of his Luminescence study are interwoven with issues in Scanning electron microscope, Nanocrystal, Photoluminescence and Transmission electron microscopy.
Within one scientific family, Yunlu Dai focuses on topics pertaining to Photosensitizer under Photodynamic therapy, and may sometimes address concerns connected to Cancer research and Carbon nitride.
He most often published in these fields:
- Nanotechnology (50.34%)
- Nanoparticle (41.61%)
- Drug delivery (26.17%)
What were the highlights of his more recent work (between 2018-2021)?
- Cancer research (13.42%)
- Nanoparticle (41.61%)
- Doxorubicin (12.75%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Cancer research, Nanoparticle, Doxorubicin, Nanotechnology and Photodynamic therapy.
His Cancer research study combines topics from a wide range of disciplines, such as Cancer cell, Tumor hypoxia, Cytotoxicity and Immunotherapy.
The various areas that Yunlu Dai examines in his Nanoparticle study include Biocompatibility, Polymer, Endocytosis, Self assembled and Combination therapy.
His Biocompatibility research includes themes of Penetration, Multifunctional nanoparticles and Photothermal therapy.
His studies in Nanotechnology integrate themes in fields like Gene delivery, Mesoporous material and Metal-organic framework.
As a member of one scientific family, he mostly works in the field of Photodynamic therapy, focusing on Photosensitizer and, on occasion, Prodrug and Combination cancer therapy.
Between 2018 and 2021, his most popular works were:
- Recent advances in nanomaterial-based synergistic combination cancer immunotherapy. (91 citations)
- Hybrid Nanomedicine Fabricated from Photosensitizer-Terminated Metal-Organic Framework Nanoparticles for Photodynamic Therapy and Hypoxia-Activated Cascade Chemotherapy. (56 citations)
- Hybrid Nanomedicine Fabricated from Photosensitizer-Terminated Metal-Organic Framework Nanoparticles for Photodynamic Therapy and Hypoxia-Activated Cascade Chemotherapy. (56 citations)
In his most recent research, the most cited papers focused on:
- Organic chemistry
- Cancer
- Polymer
Yunlu Dai focuses on Cancer research, Photodynamic therapy, Prodrug, Photosensitizer and Metal-organic framework.
In Cancer research, Yunlu Dai works on issues like Tumor hypoxia, which are connected to Nanocarriers, Nanomedicine, Chemoradiotherapy and Theranostic Nanomedicine.
He interconnects Cancer immunotherapy and Immunotherapy in the investigation of issues within Photodynamic therapy.
His biological study spans a wide range of topics, including Tumor microenvironment and Nanotechnology, Self assembled.
As part of the same scientific family, Yunlu Dai usually focuses on Metal-organic framework, concentrating on Polymerization and intersecting with Nanoparticle.
His Nanoparticle research integrates issues from Cancer treatment, Photothermal therapy, Biocompatibility, Phosphate and In situ polymerization.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
